4-[(7-Chloro-3-methyl-4-oxo-2-piperidin-1-ylmethyl-3,4-dihydro-quinazolin-6-ylmethyl)-prop-2-ynyl-amino]-N-(3-[1,2,4]triazol-1-yl-propyl)-benzamide

ID: ALA124240

PubChem CID: 10962985

Max Phase: Preclinical

Molecular Formula: C31H35ClN8O2

Molecular Weight: 587.13

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C#CCN(Cc1cc2c(=O)n(C)c(CN3CCCCC3)nc2cc1Cl)c1ccc(C(=O)NCCCn2cncn2)cc1

Standard InChI:  InChI=1S/C31H35ClN8O2/c1-3-13-39(25-10-8-23(9-11-25)30(41)34-12-7-16-40-22-33-21-35-40)19-24-17-26-28(18-27(24)32)36-29(37(2)31(26)42)20-38-14-5-4-6-15-38/h1,8-11,17-18,21-22H,4-7,12-16,19-20H2,2H3,(H,34,41)

Standard InChI Key:  HVSXTJDHNJPKFN-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 42 46  0  0  0  0  0  0  0  0999 V2000
   -0.3833   -1.9000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3292   -1.4792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3833   -2.7250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0417   -1.9000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3292   -3.1292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0417   -2.7250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4625   -1.8917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7500   -1.4875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0500   -1.1542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7542   -3.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8250   -0.6167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.7500   -1.4417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4667   -2.7167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1750   -1.4792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0958   -3.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1792   -1.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6292   -0.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8917   -1.8917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.5042   -1.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0958   -3.9625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5917   -0.6417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3042   -0.2292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3292   -0.6542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3542   -1.8917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7125   -1.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4000   -2.6792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.9417   -1.1750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9417   -2.6042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1167   -1.1792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1250   -2.6042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8917   -1.4667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0958   -1.4875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1792   -3.1292    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.8875   -1.0625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0417   -1.8625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3167   -1.4542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8083   -4.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3750   -4.3667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6125   -1.8750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3833   -5.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8083   -5.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0958   -5.6042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  2  1  0
  5  3  2  0
  6  5  1  0
  7  8  2  0
  8  4  1  0
  9 19  2  0
 10  6  1  0
 11 12  1  0
 12 35  1  0
 13 10  2  0
 14  7  1  0
 15  3  1  0
 16 24  1  0
 17 11  2  0
 18 14  1  0
 19 12  1  0
 20 15  1  0
 21 34  1  0
 22 21  3  0
 23  2  2  0
 24 28  2  0
 25 18  1  0
 26 16  2  0
 27 29  2  0
 28 30  1  0
 29 25  1  0
 30 25  2  0
 31 16  1  0
 32  1  1  0
 33 13  1  0
 34 18  1  0
 35 36  1  0
 36 39  1  0
 37 20  1  0
 38 20  1  0
 39 31  1  0
 40 38  1  0
 41 37  1  0
 42 40  1  0
  6  4  2  0
  7 13  1  0
 42 41  1  0
 24 27  1  0
 17  9  1  0
M  END

Associated Targets(Human)

WIL2 (182 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 587.13Molecular Weight (Monoisotopic): 586.2572AlogP: 3.62#Rotatable Bonds: 11
Polar Surface Area: 101.18Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 6.69CX LogP: 3.08CX LogD: 3.00
Aromatic Rings: 4Heavy Atoms: 42QED Weighted: 0.21Np Likeness Score: -1.91

References

1. Bavetsias V, Skelton LA, Yafai F, Mitchell F, Wilson SC, Allan B, Jackman AL..  (2002)  The design and synthesis of water-soluble analogues of CB30865, a quinazolin-4-one-based antitumor agent.,  45  (17): [PMID:12166942] [10.1021/jm011081s]

Source